Active Pharmaceutical Ingredient (API)
Sacubitril
Neprilysin Inhibitor (Heart Failure)
A prodrug that forms the active metabolite Sacubitrilat, which inhibits the enzyme Neprilysin (neutral endopeptidase). Neprilysin degrades natriuretic peptides ($\text{BNP}$, $\text{ANP}$), which are beneficial in heart failure. It is always combined with Valsartan in an ARNI (Angiotensin Receptor-Neprilysin Inhibitor) to treat chronic heart failure.
Technical Profile
- Reference Code
- SAC311
- CAS Number
- 149694-20-4
- Chemical Class
- N/A
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Sacubitril as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| Vymada 50 H | Novartis India Ltd | Tablet (24 mg) | ₹1,150.00 | View Details |
| Cidmus 50 H | Lupin Ltd | Tablet (24 mg) | ₹985.00 | View Details |
| Sacu V 50 H | Cipla Ltd | Tablet (24 mg) | ₹625.00 | View Details |
| Vymada 100 H | Novartis India Ltd | Tablet (49 mg) | ₹1,280.00 | View Details |
| Sidmus 100 H | Lupin Ltd | Tablet (49 mg) | ₹985.00 | View Details |